Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Immune Tolerance | 1 | 2017 | 608 | 0.46 | Why? |
Neutralization Tests | 3 | 2021 | 6698 | 0.38 | Why? |
B-Lymphocytes | 4 | 2021 | 4418 | 0.37 | Why? |
Antibodies, Neutralizing | 8 | 2021 | 25288 | 0.33 | Why? |
AIDS Vaccines | 2 | 2018 | 452 | 0.26 | Why? |
Antibodies, Monoclonal | 4 | 2021 | 8041 | 0.21 | Why? |
SARS Virus | 6 | 2021 | 13021 | 0.18 | Why? |
Cross Protection | 1 | 2021 | 373 | 0.18 | Why? |
HIV-1 | 3 | 2018 | 3365 | 0.18 | Why? |
Antibodies, Viral | 9 | 2021 | 51949 | 0.18 | Why? |
HIV Envelope Protein gp160 | 1 | 2017 | 33 | 0.18 | Why? |
Thymocytes | 1 | 2017 | 11 | 0.17 | Why? |
Nod1 Signaling Adaptor Protein | 1 | 2017 | 23 | 0.17 | Why? |
HIV Envelope Protein gp41 | 1 | 2018 | 153 | 0.17 | Why? |
Nod2 Signaling Adaptor Protein | 1 | 2017 | 39 | 0.17 | Why? |
Spike Glycoprotein, Coronavirus | 8 | 2021 | 37182 | 0.17 | Why? |
Superantigens | 1 | 2017 | 53 | 0.17 | Why? |
Cell Communication | 1 | 2017 | 396 | 0.15 | Why? |
Receptors, Antigen, B-Cell | 1 | 2017 | 424 | 0.14 | Why? |
env Gene Products, Human Immunodeficiency Virus | 1 | 2018 | 386 | 0.14 | Why? |
Germinal Center | 1 | 2017 | 332 | 0.14 | Why? |
T-Lymphocytes, Helper-Inducer | 1 | 2017 | 497 | 0.13 | Why? |
Receptors, Immunologic | 1 | 2017 | 555 | 0.12 | Why? |
Receptors, Antigen, T-Cell | 1 | 2017 | 760 | 0.11 | Why? |
Epitopes | 5 | 2021 | 4113 | 0.11 | Why? |
Antibody Affinity | 3 | 2021 | 1078 | 0.11 | Why? |
Cell Differentiation | 1 | 2017 | 1338 | 0.11 | Why? |
Protein Domains | 5 | 2021 | 6563 | 0.10 | Why? |
Severe Acute Respiratory Syndrome | 4 | 2021 | 12361 | 0.10 | Why? |
Antigenic Variation | 2 | 2021 | 249 | 0.10 | Why? |
Binding Sites, Antibody | 2 | 2021 | 466 | 0.10 | Why? |
Cross Reactions | 4 | 2021 | 4374 | 0.10 | Why? |
Protein Multimerization | 3 | 2020 | 1336 | 0.09 | Why? |
Binding Sites | 4 | 2021 | 6201 | 0.09 | Why? |
Drug Design | 1 | 2018 | 2627 | 0.08 | Why? |
MicroRNAs | 1 | 2017 | 1787 | 0.07 | Why? |
Antigens, Viral | 1 | 2021 | 6298 | 0.07 | Why? |
Animals | 8 | 2021 | 78931 | 0.06 | Why? |
Crystallography, X-Ray | 2 | 2020 | 2689 | 0.06 | Why? |
Directed Molecular Evolution | 1 | 2021 | 81 | 0.06 | Why? |
Mice | 5 | 2018 | 21357 | 0.05 | Why? |
Cohort Studies | 2 | 2021 | 36005 | 0.05 | Why? |
Cell Surface Display Techniques | 1 | 2021 | 170 | 0.05 | Why? |
CD8-Positive T-Lymphocytes | 1 | 2017 | 5837 | 0.05 | Why? |
Somatic Hypermutation, Immunoglobulin | 1 | 2020 | 283 | 0.05 | Why? |
Immunologic Memory | 2 | 2021 | 3362 | 0.05 | Why? |
Receptors, CXCR5 | 1 | 2017 | 35 | 0.05 | Why? |
B-Lymphocyte Subsets | 1 | 2020 | 372 | 0.05 | Why? |
Proto-Oncogene Proteins c-bcl-6 | 1 | 2017 | 65 | 0.05 | Why? |
Gene Knock-In Techniques | 1 | 2017 | 124 | 0.04 | Why? |
Protein Engineering | 1 | 2021 | 536 | 0.04 | Why? |
Coculture Techniques | 1 | 2017 | 258 | 0.04 | Why? |
Immunoblotting | 1 | 2017 | 180 | 0.04 | Why? |
Immunoglobulin Fc Fragments | 1 | 2021 | 691 | 0.04 | Why? |
CHO Cells | 1 | 2018 | 831 | 0.04 | Why? |
Thymus Gland | 1 | 2017 | 126 | 0.04 | Why? |
Cricetulus | 1 | 2018 | 936 | 0.04 | Why? |
Protein Stability | 1 | 2018 | 756 | 0.04 | Why? |
Antibody Specificity | 1 | 2020 | 1328 | 0.04 | Why? |
Rabbits | 1 | 2018 | 1171 | 0.04 | Why? |
Mesocricetus | 1 | 2020 | 1847 | 0.03 | Why? |
Humans | 14 | 2021 | 930598 | 0.03 | Why? |
Immunization, Passive | 2 | 2021 | 10067 | 0.03 | Why? |
Polymerase Chain Reaction | 2 | 2021 | 6740 | 0.03 | Why? |
Regression Analysis | 1 | 2021 | 2484 | 0.03 | Why? |
Protein Structure, Tertiary | 1 | 2017 | 1565 | 0.03 | Why? |
Cryoelectron Microscopy | 1 | 2020 | 2372 | 0.03 | Why? |
HIV Infections | 1 | 2018 | 11620 | 0.03 | Why? |
Betacoronavirus | 3 | 2021 | 204454 | 0.03 | Why? |
Interleukins | 1 | 2017 | 762 | 0.03 | Why? |
Mice, Knockout | 1 | 2017 | 1815 | 0.03 | Why? |
HIV Antibodies | 1 | 2017 | 776 | 0.03 | Why? |
Cricetinae | 1 | 2018 | 3344 | 0.03 | Why? |
Immune Evasion | 1 | 2021 | 2081 | 0.03 | Why? |
Mice, Transgenic | 1 | 2017 | 2739 | 0.03 | Why? |
Mutation | 2 | 2021 | 12376 | 0.03 | Why? |
Mice, Inbred BALB C | 1 | 2021 | 5814 | 0.03 | Why? |
Flow Cytometry | 1 | 2017 | 2393 | 0.02 | Why? |
Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.02 | Why? |
Dendritic Cells | 1 | 2017 | 1330 | 0.02 | Why? |
Protein Conformation | 1 | 2018 | 4386 | 0.02 | Why? |
Immunity, Humoral | 1 | 2021 | 4849 | 0.02 | Why? |
Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
Female | 6 | 2021 | 380317 | 0.02 | Why? |
Cell Line | 1 | 2020 | 12040 | 0.02 | Why? |
Protein Binding | 1 | 2021 | 11430 | 0.02 | Why? |
HEK293 Cells | 1 | 2017 | 8394 | 0.02 | Why? |
Receptors, Virus | 1 | 2020 | 5659 | 0.02 | Why? |
Male | 5 | 2021 | 367725 | 0.01 | Why? |
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 7868 | 0.01 | Why? |
Disease Models, Animal | 1 | 2020 | 10998 | 0.01 | Why? |
Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
Virus Replication | 1 | 2020 | 14331 | 0.01 | Why? |
Adult | 3 | 2021 | 244371 | 0.01 | Why? |
Middle Aged | 3 | 2021 | 270681 | 0.01 | Why? |
Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
Aged | 2 | 2021 | 215776 | 0.01 | Why? |
Pandemics | 1 | 2020 | 389249 | 0.01 | Why? |
Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
Lung | 1 | 2020 | 31049 | 0.01 | Why? |
Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |
Nemazee's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(103)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(128)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_